Global High-Throughput Screening (HTS) for Drug Discovery Market Growth 2024-2030

Global High-Throughput Screening (HTS) for Drug Discovery Market Growth 2024-2030

High-Throughput Screening (HTS) is a powerful method used in drug discovery to quickly assess the biological or biochemical activity of a large number of compounds. This technique involves the automation of experiments to evaluate thousands to millions of samples for their potential as drug candidates.

The global High-Throughput Screening (HTS) for Drug Discovery market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “High-Throughput Screening (HTS) for Drug Discovery Industry Forecast” looks at past sales and reviews total world High-Throughput Screening (HTS) for Drug Discovery sales in 2023, providing a comprehensive analysis by region and market sector of projected High-Throughput Screening (HTS) for Drug Discovery sales for 2024 through 2030. With High-Throughput Screening (HTS) for Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-Throughput Screening (HTS) for Drug Discovery industry.

This Insight Report provides a comprehensive analysis of the global High-Throughput Screening (HTS) for Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High-Throughput Screening (HTS) for Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High-Throughput Screening (HTS) for Drug Discovery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-Throughput Screening (HTS) for Drug Discovery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-Throughput Screening (HTS) for Drug Discovery.

United States market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for High-Throughput Screening (HTS) for Drug Discovery is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key High-Throughput Screening (HTS) for Drug Discovery players cover Thermo Fisher Scientific, Agilent, Merck, Danaher, Revvity, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of High-Throughput Screening (HTS) for Drug Discovery market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Consumables
Instruments

Segmentation by Application:
Pharmaceuticals
Biological Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent
Merck
Danaher
Revvity
Tecan Group
Bio-Rad Laboratories
Corning Incorporated
Mettler-Toledo International
Lonza
Waters Corporation
Sartorius AG
Eppendorf
Porvair
Greiner AG
Charles River Laboratories
Eurofins Scientific
Hamilton
Aurora Biomed
Gilson
Brand GmbH+Co
BMG Labtech
DIANA Biotechnologies
Creative Biolabs
HighRes Biosolutions
Biomat
AXXAM S.p.A.
Sygnature Discovery
Crown Bioscience

Key Questions Addressed in this Report

What is the 10-year outlook for the global High-Throughput Screening (HTS) for Drug Discovery market?

What factors are driving High-Throughput Screening (HTS) for Drug Discovery market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do High-Throughput Screening (HTS) for Drug Discovery market opportunities vary by end market size?

How does High-Throughput Screening (HTS) for Drug Discovery break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.